logo
Plus   Neg
Share
Email

Dassault Systèmes To Buy Medidata Solutions In $5.8 Bln Deal - Quick Facts

French software company Dassault Systèmes (DASTY.PK) announced Wednesday that it has signed an agreement to acquire Medidata Solutions, Inc. (MDSO) in an all-cash transaction at a price of $ 92.25 per share. The deal represents an enterprise value of $5.8 billion for Medidata.

The transaction was unanimously approved by the Boards of Directors of both companies.

The deal is expected to close during the last quarter of 2019 and is subject to certain regulatory approvals, approval by the majority of Medidata's shareholders and other customary closing conditions.

U.S.-based Medidata engages in the digital transformation of the Life Sciences industry for clinical development, commercial, and data intelligence. The company's revenues for fiscal 2018 were $636 million.

Medidata provides clinical expertise and cloud-based solutions for 1,300 customers worldwide. In 2018, thirteen of the top 15 drugs sold were powered by Medidata's technology.

Dassault Systèmes expects the acquisition of Medidata and its clinical and commercial solutions, would help it to reinforce its position as a science-based company.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple chief executive officer Tim Cook condemned the killing of an unarmed black man, George Floyd, and called for the creation of a "better, more just world for everyone," according to reports citing a memo to employees. Apotex Corp. recalled all lots of type 2 diabetes medication Metformin hydrochloride in the form of oral film-coated tablets for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels of the Acceptable Daily Intake Limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement. Groupe Renault plans to cut about 14,600 jobs across the world and lower its production capacity. The plan includes almost 4,600 jobs reduction in France, through voluntary retirement and retraining.
Follow RTT